HS

Hans-Peter Schwarz

BS Baxter Healthcare Sa: 34 patents #11 of 1,132Top 1%
BI Baxter International: 34 patents #19 of 2,334Top 1%
BI Baxalta Incorporated: 29 patents #1 of 230Top 1%
IA Immuno Aktiengesellschaft: 27 patents #3 of 75Top 4%
BA Baxter Aktiengesellschaft: 18 patents #3 of 86Top 4%
TL Takeda Pharmaceutical Company Limited: 6 patents #248 of 1,531Top 20%
BG Baxter Innovations Gmbh: 4 patents #4 of 22Top 20%
SB Stichting Sanquin Bloedvoorziening: 3 patents #6 of 43Top 15%
📍 Wien, AT: #3 of 3,624 inventorsTop 1%
Overall (All Time): #9,130 of 4,157,543Top 1%
125
Patents All Time

Issued Patents All Time

Showing 101–125 of 125 patents

Patent #TitleCo-InventorsDate
5880265 Method for isolation of highly pure von willebrand factor Bernhard Fischer, Artur Mitterer, Friedrich Dorner, Peter Turecek, Johann Eibl +5 more 1999-03-09
5877152 Method for isolation of highly pure von Willebrand Factor Bernhard Fischer, Artur Mitterer, Friedrich Dorner, Peter Turecek, Johann Eibl +5 more 1999-03-02
5866122 Pharmaceutical preparation for treating blood coagulation disorders Peter Turecek, Johann Eibl 1999-02-02
5863896 Evaluation of substances for altering and for increasing APC response Jan Rosing, Guido Tans, Katalin Varadi 1999-01-26
5854403 Method for isolation of highly pure von Willebrand Factor Bernhard Fischer, Artur Mitterer, Friedrich Dorner, Peter Turecek, Johann Eibl +5 more 1998-12-29
5830467 Pharmaceutical preparation containing protein C and a thrombolytically active substance Johann Eibl, Anton Philapitsch 1998-11-03
5827818 Agent for subcutaneous administration of protein C Johann Eibl 1998-10-27
5804159 Antiplasma animal model Johann Eibl, Peter Turecek 1998-09-08
5804181 Pharmaceutical preparation for the prevention and treatment of blood coagulation disorders Johann Eibl, Katalin Varadi 1998-09-08
5776452 Thrombosis agent Johann Eibl, Anton Philapitsch 1998-07-07
5698677 Stable preparation for the treatment of blood coagulation disorders Johann Eibl, Jürgen Siekmann, Peter Turecek 1997-12-16
5675058 Bioassay for thrombogenesis and rabbit model Johann Eibl, Ludwig Pichler 1997-10-07
5643739 Assay for determining sensitivity to activated protein C Katalin Varadi, Hartmut Lang, Berta Moritz 1997-07-01
5614493 Use of human protein C for prevention and treatment of depositions of thrombocytes Johann Eibl, Miguel Lozano-Molero 1997-03-25
5597800 Treatment with lys-plasminogen of reperfusion injury and brain edema caused by ischemia Johann Eibl, Ludwig Pichler 1997-01-28
5593968 Virus-inactivated factor Xa preparation Peter Turecek, Eibl Johann 1997-01-14
5580962 Parenterally administrable drug having thrombolytic activity and containing protein C Johann Eibl, Yendra Linnau, Anton Philapitsch 1996-12-03
5571786 Use of protein C or the activation peptide of protein C for preparing a pharmaceutical preparation Johann Eibl, Ludwig Pichler, Peter Turecek 1996-11-05
5549893 Use of protein C in the treatment of purpura fulminans Johann Eibl, Ludwig Pichler 1996-08-27
5520912 Prevention and treatment of ischemic events and reperfusion injury resulting therefrom using lys-plasminogen Johann Eibl, Ludwig Pichler 1996-05-28
5478558 Method of dissolving venous Thrombi using drug containing activated Protein C Johann Eibl, Yendra Linnau, Anton Philapitsch 1995-12-26
5330907 Method of preparing activated protein C Anton Philapitsch 1994-07-19
5304383 Pharmaceutical preparation based on Lys-plasminogen Johann Eibl, Anton Philapitsch 1994-04-19
5254532 Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same Ewald Molinari, Yendra Linnau, Susanne Pfeiler 1993-10-19
5143901 Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same Ewald Molinari, Yendra Linnau, Susanne Pfeiler 1992-09-01